Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
REGULATORY T CELL EPITOPE, COMPOSITION, AND USE THEREOF
Document Type and Number:
Japanese Patent JP2021107443
Kind Code:
A
Abstract:
To provide an artificial induction technology of immune tolerance to self or foreign antigens, which overcomes autoimmune diseases, transplantation related disorders, allergic reactions, immune rejection of therapeutic proteins, etc.SOLUTION: According to the present invention, a T cell epitope (Tregitope) was identified using a common autologous protein, such as the constant region of IgG, the Tregitope being capable of binding to and activating natural T regulatory cells (TReg) through the binding to a major histocompatibility complex (MHC) molecule. The selective involvement and activation of Treg through the use of Tregitope and Tregitope antigen fusions is therapeutically useful as a means of treating any disease or condition characterized by the presence of an unwanted immune response. If Tregitope modified Fc, which is modified to be incapable of binding to MHC and Treg, can be used as a vaccine delivery vector, a vaccine antigen is allowed to be efficiently targeted.SELECTED DRAWING: Figure 1

Inventors:
DE GROOT ANNE
MARTIN WILLIAM
RIVERA DAN
Application Number:
JP2021072446A
Publication Date:
July 29, 2021
Filing Date:
April 22, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
EPIVAX INC
International Classes:
C07K14/725; A61K38/10; A61K38/16; A61K39/00; A61K39/35; A61P37/06; A61P37/08; A61P43/00; C07K7/08; C12N5/0783
Foreign References:
WO2006082406A22006-08-10
Other References:
PNAS, vol. 103, JPN6015040859, 2006, pages 11683 - 11688, ISSN: 0004771982
THE LANCET, vol. 366, JPN6015040860, 2005, pages 50 - 56, ISSN: 0004771983
Attorney, Agent or Firm:
Hatsushi Shimizu
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Masato Ozeki
Kazuya Kawamoto